Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

543 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease.
Cohen JL, Ottenweller JE, George AK, Duvvuri S. Cohen JL, et al. Am J Cardiol. 1993 Dec 1;72(17):1226-31. doi: 10.1016/0002-9149(93)90288-n. Am J Cardiol. 1993. PMID: 8256696
Two-dimensional echocardiographic findings in patients on hemodialysis for more than six months.
Cohen JL, Barooah B, Segal KR, Batuman V. Cohen JL, et al. Am J Cardiol. 1987 Sep 15;60(8):743-5. doi: 10.1016/0002-9149(87)90401-2. Am J Cardiol. 1987. PMID: 3310593 No abstract available.
Dobutamine digital echocardiography for detecting coronary artery disease.
Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Cohen JL, et al. Am J Cardiol. 1991 Jun 15;67(16):1311-8. doi: 10.1016/0002-9149(91)90457-v. Am J Cardiol. 1991. PMID: 2042561
Usefulness of oral dipyridamole digital echocardiography for detecting coronary artery disease.
Cohen JL, Greene TO, Alston JR, Wilchfort SD, Kim CS. Cohen JL, et al. Am J Cardiol. 1989 Aug 1;64(5):385-6. doi: 10.1016/0002-9149(89)90540-7. Am J Cardiol. 1989. PMID: 2756884 No abstract available.
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
Grayburn PA, Weiss JL, Hack TC, Klodas E, Raichlen JS, Vannan MA, Klein AL, Kitzman DW, Chrysant SG, Cohen JL, Abrahamson D, Foster E, Perez JE, Aurigemma GP, Panza JA, Picard MH, Byrd BF 3rd, Segar DS, Jacobson SA, Sahn DJ, DeMaria AN. Grayburn PA, et al. Among authors: cohen jl. J Am Coll Cardiol. 1998 Jul;32(1):230-6. doi: 10.1016/s0735-1097(98)00219-8. J Am Coll Cardiol. 1998. PMID: 9669275 Clinical Trial.
Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease.
Harnick DJ, Cohen JL, Schechter CB, Fuster V, Smith DA. Harnick DJ, et al. Among authors: cohen jl. Am J Cardiol. 1998 Jun 15;81(12):1416-20. doi: 10.1016/s0002-9149(98)00209-4. Am J Cardiol. 1998. PMID: 9645890
Safety and efficacy of closed-loop arbutamine stress echocardiography for detection of coronary artery disease. International Arbutamine Study Group.
Bach DS, Cohen JL, Fioretti PM, Ginzton LE, Sklar J, Zabalgoitia M, Crouse L. Bach DS, et al. Among authors: cohen jl. Am J Cardiol. 1998 Jan 1;81(1):32-5. doi: 10.1016/s0002-9149(97)00800-x. Am J Cardiol. 1998. PMID: 9462602 Clinical Trial.
Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study.
Steinberg EH, Madmon L, Patel CP, Sedlis SP, Kronzon I, Cohen JL. Steinberg EH, et al. Among authors: cohen jl. J Am Coll Cardiol. 1997 Apr;29(5):969-73. doi: 10.1016/s0735-1097(97)00032-6. J Am Coll Cardiol. 1997. PMID: 9120183
Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The International Arbutamine Study Group.
Cohen JL, Chan KL, Jaarsma W, Bach DS, Muller DW, Starling MR, Armstrong WF. Cohen JL, et al. J Am Coll Cardiol. 1995 Nov 1;26(5):1168-75. doi: 10.1016/0735-1097(95)00296-0. J Am Coll Cardiol. 1995. PMID: 7594028 Clinical Trial.
Effect of atenolol or metoprolol on arbutamine stress echocardiography in patients suspected of having coronary artery disease.
Weissman NJ, Sheris SJ, Picard MH, Bach DS, Sklar J, Cohen JL. Weissman NJ, et al. Among authors: cohen jl. Am J Cardiol. 1998 Sep 15;82(6):830-2, A10. doi: 10.1016/s0002-9149(98)00479-2. Am J Cardiol. 1998. PMID: 9761104 Clinical Trial.
543 results
Jump to page
Feedback